[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"atrioventricular-block-second-and-third-degree\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:atrioventricular-block-second-and-third-degree":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,81],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":4},"100619774","predicting-severe-cardiac-arrhythmias-in-the-perioperative-period-using-ai-ecg-100619774",false,"NCT07348991","Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECG","Predicting Atrial Fibrillation and Life-threatening Cardiac Arrhythmias and Conduction Disorders in the Perioperative Period in High Cardiac Risk Surgery Using Artificial Intelligence Elements","Inclusion Criteria:\n\n* Patients over 18 years of age;\n* Scheduled surgery with high cardiac risk\n* Informed consent was given to participate in the study\n\nExclusion Criteria:\n\n* Cancellation of the surgery for any reason;\n* The patient's unwillingness to continue participating in the study;\n* Poor quality of the ECG recording on a single-channel ECG monitor.","ALL","18 Years",{"count":19,"type":20},300,"ESTIMATED","OBSERVATIONAL","During the preoperative examination, in addition to the standard examination recommended before high-risk cardiac surgeries, a digital single-lead ECG is recorded using portable CardioQUARK devices. This ECG is analyzed for time, amplitude, and frequency parameters-more than 200 parameters per cardiac cycle. Additionally, the available parameters of a standard 12-lead ECG recording are determined. All parameters of both single-lead and 12-lead ECGs will be included in a multivariate regression analysis to determine the optimal method for predicting atrial fibrillation, life-threatening cardiac arrhythmias, and conduction abnormalities in the perioperative period after high-risk cardiac procedures.\n\nThe study will include patients undergoing high-risk cardiac surgeries, such as those on the heart, aorta, esophagus, pancreas, liver, and lungs, as well as high-risk oncological surgeries. A partial analysis will also be performed depending on the type of intervention. Rhythm and conduction disturbances will be recorded during surgery, as well as in the postoperative period, using ECG monitors, 24-hour ECG monitoring, and repeated recordings of a standard ECG when complaints or signs of unstable hemodynamics arise",[24,25,26,27,28],"Atrial Fibrillation","Atrioventricular Block, Second and Third Degree","Sinus Node Dysfunction","Ventricular Tachycardia (VT)","Ventricular Fibrillation",[30,31,32,33,34,35],"Electrocardiogram","Artificial intelligence","Cardiac arrhythmias","Atrioventricular block","Perioperative","Atrial fibrillation","NOT_YET_RECRUITING","2026-02-09",{"date":39,"type":40},"2026-02-10","ACTUAL",{"date":42,"type":20},"2026-12-31",{"date":44,"type":20},"2028-05-30",{"name":46,"class":47},"I.M. Sechenov First Moscow State Medical University","OTHER",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":63,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":80},"100513531","physiologic-cardiac-pacing-to-prevent-left-ventricular-dysfunction-post-tavi-100513531","NCT05966675","Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI","Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post Transcatheter Aortic Valve Implantation","PACE-4-TAVI","Inclusion Criteria:\n\n1. transcatheter aortic valve implantation (TAVI) in up to 30 days before qualification to pacemaker implantation\n2. Fulfilled criteria for permanent pacemaker implantation according do 2021 ESC guidelines\n3. Written informed consent\n4. Age of at least 18 years\n\nExclusion Criteria:\n\n1. Permanent pacemaker implantation before TAVI procedure\n2. The occurrence of conduction disturbances more than 30 days after TAVI procedure\n3. No written informed consent\n4. Inability to obtain informed consent from participant\n5. Predicted inability to obtain cooperation from patient during observation period",{"count":57,"type":20},500,"INTERVENTIONAL",[60],"NA","The study aims to compare permanent Conduction System Pacing (CSP) with the standard therapy - Right Ventricular Pacing (RVP) or Biventricular Pacing (BVP) - in preventing the development and progression of symptomatic Chronic Heart Failure (CHF) and improving survival in patients after Transcatheter Aortic Valve Implantation (TAVI).",[25],[64,65,66,67,68,69],"Pacemaker","Transcatheter Aortic Valve Replacement","Conduction System Pacing (CSP)","Atrioventricular Block","Congestive Heart Failure","Bradycardia","RECRUITING","2025-06-04",{"date":73,"type":40},"2025-06-08",{"date":75,"type":40},"2024-02-27",{"date":77,"type":20},"2028-06",{"name":79,"class":47},"Medical University of Silesia",1,{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":58,"phases":91,"briefSummary":92,"conditions":93,"keywords":96,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":112},"100566251","evaluating-the-safety-and-effectiveness-of-5g-cloud-follow-up-for-cardiovascular-implantable-electronic-devices-100566251","NCT06652750","Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices","Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices: a Prospective, Paired, Self-controlled, Non-inferiority, Multicenter Clinical Trial","CIED-CARE","Inclusion Criteria:\n\n1. Age ≥ 18 years, gender unspecified;\n2. Patients who have not undergone their first clinic follow-up after the implantation of cardiovascular implantable electronic devices (CIED); Note: In this study, CIED includes pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy pacemakers (CRT-P) and defibrillators (CRT-D), excluding implantable cardiac event recorders (ICM) and implantable cardiovascular monitors.\n3. Willing to participate in this clinical study and have signed the informed consent form in writing.\n\nExclusion Criteria:\n\n* Exclusion Criteria:\n\nIf meeting any of the following, the individual cannot be included:\n\n1. Life expectancy \\\u003C 1 year.\n2. Inability to cooperate with treatment or follow-up, such as having mental illness.\n3. Participated in other clinical studies within 30 days before enrollment. Other situations that the researcher deems unsuitable for inclusion.",{"count":90,"type":20},688,[60],"Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation.\n\nParticipants will:\n\nundergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit",[94,25,95],"Sick Sinus Syndrome","Heart Failure",[97,98,99,100,101,102],"pacemaker","implantable cardioverter defibrillator","cardiac resynchronization therapy","follow up","remote programming","in-office follow-up","2024-11-18",{"date":105,"type":40},"2024-11-21",{"date":107,"type":40},"2024-11-13",{"date":109,"type":20},"2026-02-01",{"name":111,"class":47},"The Third People's Hospital of Chengdu",2]